T1	Participants 0 59	Evaluation of mood profiles during malaria chemoprophylaxis
T2	Participants 161 332	users of malaria chemoprophylaxis regimens (atovaquone-proguanil, chloroquine-proguanil, doxycycline, or mefloquine) in a group of nonimmune tourists to sub-Saharan Africa
T3	Participants 427 478	travel clinics in Switzerland, Germany, and Israel,
T4	Participants 513 543	chemoprophylaxis users (n= 547
T5	Participants 1323 1328	women
T6	Participants 1416 1419	men
T7	Participants 1444 1501	age group (below median age 34 y vs median age and above)
T8	Participants 1627 1655	those aged 34 years and olde
T9	Participants 1658 1694	Younger participants, aged <34 years
